Ravgen’s core technology is based on its ability to increase the percentage of fetal DNA that is found in the mother’s blood. Through its research with free-floating fetal DNA, the company has developed and patented a variety of noninvasive prenatal tests that simply require a routine blood draw from the mother. Currently, the focus for Ravgen’s core technology is on testing for single gene disorders, such as cystic fibrosis, sickle cell anemia, and the Jewish panel, as well as prenatal paternity testing.
To complete our Prenatal DNA Paternity test, we require a safe blood draw from the mother’s arm and a buccal swab collection from the potential father to match the baby’s DNA with a potential father’s DNA. We can conduct the paternity test with over 99% accuracy.
For the sample collections, you do not need to come to our lab directly. We work with numerous site in the United States and Canada. Please contact Ravgen at (410) 715-2111 for specific locations.